Newly Approved Aucatzyl Provides New Hope Against a Tough-to-Treat Leukemia in Adults

TUESDAY, Dec. 3, 2024 -- A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show.

Aucatzyl (obecabtagene autoleucel) worked on more than three-quarters (76%) of patients with B-cell...